March 24th 2023
An expert panel highlights novel therapeutic approaches for newly diagnosed and relapsed multiple myeloma.
Role of Transplant and Induction Therapies in NDMM
Expert perspectives on the role of transplants and induction therapy in patients with newly diagnosed multiple myeloma (NDMM).
Selecting Treatment Regimens for Multiple Myeloma at First Relapse
Turning to the last module, expert panelists discuss the treatment armamentarium for patients experiencing early relapse in multiple myeloma.
Choosing the Right Treatment for Patients With Transplant Ineligible MM
Patient and disease factors that help to select best first-line therapy in the setting of transplant-ineligible multiple myeloma.
Induction Regimen Options in Transplant-Eligible NDMM
Opening their discussion on transplant-eligible newly diagnosed multiple myeloma (NDMM), expert panelists review induction regimen options for patients.
Approaching Induction Therapy for Patients With Transplant-Ineligible MM
Switching their focus to transplant-ineligible multiple myeloma, panelists review available triplet therapy regimens for induction therapy.
Selecting The Appropriate Treatment in Transplant-Eligible Newly Diagnosed MM
A brief discussion how to select the appropriate treatment strategy in transplant-eligible newly diagnosed myeloma and whether there is a role for minimal residual disease in assessing response and treatment duration.